Eli Lilly (LLY) Intangibles (2010 - 2026)

Eli Lilly (LLY) has reported Intangibles for 16 consecutive years, with $7.4 billion the latest figure, recorded in Q1 2026.

• Intangibles for Q1 2026 came in at $7.4 billion, up 22.65% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.4 billion (up 22.65% YoY), and the FY2025 annual result was $6.5 billion, up 5.76% from the prior year.
• Intangibles was $7.4 billion for Q1 2026 at Eli Lilly, up from $6.5 billion in the prior quarter.
• Over five years, Intangibles peaked at $7.5 billion in Q2 2022 and troughed at $5.9 billion in Q2 2025.
• Average Intangibles over 5 years is $6.8 billion, with a median of $6.8 billion recorded in 2023.
• Year-over-year, Intangibles declined 11.09% in 2025 and gained 22.65% in 2026.
• Over 5 years, Intangibles stood at $7.2 billion in 2022, then dropped by 4.16% to $6.9 billion in 2023, then declined by 10.72% to $6.2 billion in 2024, then advanced by 5.76% to $6.5 billion in 2025, then grew by 13.08% to $7.4 billion in 2026.
• Per Business Quant data, the three most recent Intangibles figures were $7.4 billion in Q1 2026, $6.5 billion in Q4 2025, and $6.4 billion in Q3 2025.